crizanlizumab
0 sources
crizanlizumab
Summary
crizanlizumab is a monoclonal antibody[1]. crizanlizumab draws 53 Wikipedia views per month (monoclonal_antibody category, ranking #10 of 31).[2]
Key Facts
- crizanlizumab's instance of is recorded as monoclonal antibody[3].
- crizanlizumab's medical condition treated is recorded as vaso-occlusive crisis[4].
- crizanlizumab's World Health Organisation international non-proprietary name is recorded as {'lang': 'en', 'text': 'crizanlizumab'}[5].
- crizanlizumab's active ingredient in is recorded as Adakveo[6].
Why It Matters
crizanlizumab draws 53 Wikipedia views per month (monoclonal_antibody category, ranking #10 of 31).[2] crizanlizumab has Wikipedia articles in 7 language editions, a strong signal of global cultural recognition.[7]